Cargando…

Mengo virus as a vector for expression of foreign polypeptides; hepatitis A virus, HIV virus, rabies virus, foot-and-mouth-disease virus, coronat virus, Rous sarcoma virus, herpes virus, etc., live attenuated recombinant vaccine : Inst. Pasteur Paris World 9429 472; 22 December 1994

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 1995
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131182/
http://dx.doi.org/10.1016/0264-410X(95)90206-5
_version_ 1783517180492513280
collection PubMed
description
format Online
Article
Text
id pubmed-7131182
institution National Center for Biotechnology Information
language English
publishDate 1995
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71311822020-04-08 Mengo virus as a vector for expression of foreign polypeptides; hepatitis A virus, HIV virus, rabies virus, foot-and-mouth-disease virus, coronat virus, Rous sarcoma virus, herpes virus, etc., live attenuated recombinant vaccine : Inst. Pasteur Paris World 9429 472; 22 December 1994 Vaccine Article Published by Elsevier Ltd. 1995 2003-10-11 /pmc/articles/PMC7131182/ http://dx.doi.org/10.1016/0264-410X(95)90206-5 Text en Copyright © 1995 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mengo virus as a vector for expression of foreign polypeptides; hepatitis A virus, HIV virus, rabies virus, foot-and-mouth-disease virus, coronat virus, Rous sarcoma virus, herpes virus, etc., live attenuated recombinant vaccine : Inst. Pasteur Paris World 9429 472; 22 December 1994
title Mengo virus as a vector for expression of foreign polypeptides; hepatitis A virus, HIV virus, rabies virus, foot-and-mouth-disease virus, coronat virus, Rous sarcoma virus, herpes virus, etc., live attenuated recombinant vaccine : Inst. Pasteur Paris World 9429 472; 22 December 1994
title_full Mengo virus as a vector for expression of foreign polypeptides; hepatitis A virus, HIV virus, rabies virus, foot-and-mouth-disease virus, coronat virus, Rous sarcoma virus, herpes virus, etc., live attenuated recombinant vaccine : Inst. Pasteur Paris World 9429 472; 22 December 1994
title_fullStr Mengo virus as a vector for expression of foreign polypeptides; hepatitis A virus, HIV virus, rabies virus, foot-and-mouth-disease virus, coronat virus, Rous sarcoma virus, herpes virus, etc., live attenuated recombinant vaccine : Inst. Pasteur Paris World 9429 472; 22 December 1994
title_full_unstemmed Mengo virus as a vector for expression of foreign polypeptides; hepatitis A virus, HIV virus, rabies virus, foot-and-mouth-disease virus, coronat virus, Rous sarcoma virus, herpes virus, etc., live attenuated recombinant vaccine : Inst. Pasteur Paris World 9429 472; 22 December 1994
title_short Mengo virus as a vector for expression of foreign polypeptides; hepatitis A virus, HIV virus, rabies virus, foot-and-mouth-disease virus, coronat virus, Rous sarcoma virus, herpes virus, etc., live attenuated recombinant vaccine : Inst. Pasteur Paris World 9429 472; 22 December 1994
title_sort mengo virus as a vector for expression of foreign polypeptides; hepatitis a virus, hiv virus, rabies virus, foot-and-mouth-disease virus, coronat virus, rous sarcoma virus, herpes virus, etc., live attenuated recombinant vaccine : inst. pasteur paris world 9429 472; 22 december 1994
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131182/
http://dx.doi.org/10.1016/0264-410X(95)90206-5